S F Hunter|D A Hafler - JoVE Visualize

Showing results (141-150 of 164) with videos related to

Pageof 17

Sort By:

Clinical Immunology and Immunopathology|November 1, 1985

Investigation of in vivo activated T cells in multiple sclerosis and inflammatory central nervous system diseasesD A Hafler, M E Hemler, L Christenson, et al.

Multiple Sclerosis (Houndmills, Basingstoke, England)|January 5, 2000

Treatment of progressive multiple sclerosis with pulse cyclophosphamide/methylprednisolone: response to therapy is linked to the duration of progressive diseaseM J Hohol, M J Olek, E J Orav, et al.

The Journal of Experimental Medicine|May 1, 1988

Distinct molecular forms of human T cell receptor gamma/delta detected on viable T cells by a monoclonal antibodyJ Borst, J J van Dongen, R L Bolhuis, et al.

Proceedings of the National Academy of Sciences of the United States of America|June 7, 2000

Multiple differences in gene expression in regulatory Valpha 24Jalpha Q T cells from identical twins discordant for type I diabetesS B Wilson, S C Kent, H F Horton, et al.

Journal of Virology|October 29, 1997

The immune system preferentially clears Theiler's virus from the gray matter of the central nervous systemM K Njenga, K Asakura, S F Hunter, et al.

Neurology|July 1, 1996

Traumatic occlusion of one limb of an intracranial arterial fenestration: an uncommon cause of strokeW I Schievink, S F Hunter, W R Marsh, et al.

Annual Review of Immunology|January 1, 1994

Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigensH L Weiner, A Friedman, A Miller, et al.

Neurology|September 17, 2008

CTLA4Ig treatment in patients with multiple sclerosis: an open-label, phase 1 clinical trialV Viglietta, K Bourcier, G J Buckle, et al.

Neurology|May 1, 1993

Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment GroupH L Weiner, G A Mackin, E J Orav, et al.

Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1992

CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine productionG J Freeman, D B Lombard, C D Gimmi, et al.

Pageof 17

Showing results (141-150 of 164) with videos related to

Sort By:

Pageof 17

Clinical Immunology and Immunopathology|November 1, 1985

Investigation of in vivo activated T cells in multiple sclerosis and inflammatory central nervous system diseasesD A Hafler, M E Hemler, L Christenson, et al.

Multiple Sclerosis (Houndmills, Basingstoke, England)|January 5, 2000

Treatment of progressive multiple sclerosis with pulse cyclophosphamide/methylprednisolone: response to therapy is linked to the duration of progressive diseaseM J Hohol, M J Olek, E J Orav, et al.

The Journal of Experimental Medicine|May 1, 1988

Distinct molecular forms of human T cell receptor gamma/delta detected on viable T cells by a monoclonal antibodyJ Borst, J J van Dongen, R L Bolhuis, et al.

Proceedings of the National Academy of Sciences of the United States of America|June 7, 2000

Multiple differences in gene expression in regulatory Valpha 24Jalpha Q T cells from identical twins discordant for type I diabetesS B Wilson, S C Kent, H F Horton, et al.

Journal of Virology|October 29, 1997

The immune system preferentially clears Theiler's virus from the gray matter of the central nervous systemM K Njenga, K Asakura, S F Hunter, et al.

Neurology|July 1, 1996

Traumatic occlusion of one limb of an intracranial arterial fenestration: an uncommon cause of strokeW I Schievink, S F Hunter, W R Marsh, et al.

Annual Review of Immunology|January 1, 1994

Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigensH L Weiner, A Friedman, A Miller, et al.

Neurology|September 17, 2008

CTLA4Ig treatment in patients with multiple sclerosis: an open-label, phase 1 clinical trialV Viglietta, K Bourcier, G J Buckle, et al.

Neurology|May 1, 1993

Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment GroupH L Weiner, G A Mackin, E J Orav, et al.

Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1992

CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine productionG J Freeman, D B Lombard, C D Gimmi, et al.

Pageof 17